AtaiBeckley (ATAI) Change in Account Payables (2020 - 2026)
AtaiBeckley (ATAI) recorded quarterly Change in Account Payables of $6.0 million in Q1 2026, up 16447.22% quarter-over-quarter from $36000.0 in Q1 2025, and up 16447.22% on a YoY basis from N/an in Q1 2025.
AtaiBeckley (ATAI) Change in Account Payables (2020 - 2026) Analysis & Trends
AtaiBeckley has disclosed Change in Account Payables across 6 years of filings, most recently posting $1.8 million for Q3 2025.
- Change in Account Payables for Q3 2025 came in at $1.8 million, up 71.9% year-over-year; the trailing twelve-month figure through Sep 2025 was $442000.0 (up 163.41% YoY), and the FY2024 annual result was -$1.9 million, down 187.56% from the prior year.
- Change in Account Payables was $6.0 million for Q1 2026 at AtaiBeckley, up from $36000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $6.0 million in Q1 2026 to a low of $36000.0 in Q1 2025.
- The 5-year median for Change in Account Payables is -$22000.0 (2024), against an average of $110894.7.
- Across the five-year window, Change in Account Payables plunged 1138.72% in 2021 and jumped 3631.82% in 2025, its largest moves.
- AtaiBeckley's Change in Account Payables stood at $4.0 million in 2021, then tumbled by 115.06% to -$598000.0 in 2022, then sank by 60.2% to -$958000.0 in 2023, then slumped by 122.65% to -$2.1 million in 2024, then soared by 182.61% to $1.8 million in 2025.
- The last three Change in Account Payables figures came in at $1.8 million (Q3 2025), $777000.0 (Q2 2025), and $36000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | 5.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.96 Mn |
| Mar 31, 2026 | 5.96 Mn |
| Sep 30, 2025 | 1.76 Mn |
| Sep 30, 2025 | 1.76 Mn |
| Jun 30, 2025 | 777,000.00 |
| Jun 30, 2025 | 777,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | -2.13 Mn |
| Dec 31, 2024 | -2.13 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | -22,000.00 |
| Jun 30, 2024 | -22,000.00 |
| Mar 31, 2024 | -742,000.00 |
| Mar 31, 2024 | -742,000.00 |
| Dec 31, 2023 | -958,000.00 |
| Dec 31, 2023 | -958,000.00 |